A recent 3-month randomized, open-label controlled trial found that the intra-articular hyaluronic acid injection (GO-ON
All the 127 patients, who received either three repeated doses (
A total of 125 patients (98.4%) completed the assessment. Despite the reduction of the overall mean WOMAC score from 39.24 to 19.93 (
These findings indicate that the single larger dose of GO-ON is as effective as the repeated doses over 12 months, and yet the total treatment cost is lowered.